Research Topics
Genomes and GenesSpecies | K LacutSummaryAffiliation: Brest University Hospital Country: France Publications
| Collaborators
|
Detail Information
Publications
Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?Emmanuel Oger
Groupe d Etude de la Thrombose de Bretagne Occidentale, Department of Internal Medicine and Chest Diseases, Hopital de la Cavale Blanche, F 29609 Brest Cedex, France
Thromb Haemost 88:587-91. 2002..8, 95% CI, 0.4 to 1.7). Age appeared as an effect-measure modifier with a significant interaction (p = 0.005). Our data suggest that APC resistance is not a risk factor for VTE in elderly...
Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindioneKarine Lacut
EA 3878, Universite de Bretagne Occidentale, F 29609 Brest, France
Br J Clin Pharmacol 73:428-36. 2012..The role of these variants in fluindione response is unknown. Our aim was to assess whether genetic factors contribute to the variability in the response to fluindione...
[Mechanical prophylaxis of venous thromboembolism]Karine Lacut
centre d investigation clinique, CHRU de Brest, Hopital de la Cavale Blanche, 29609 Brest Cedex
Rev Prat 61:1232-6. 2011..They highlight the need to assess or re-evaluate mechanical devices by rigorous clinical trials...
[Do observational studies have a role in assessing treatment?]Karine Lacut
EA 3878 Groupe d Etude de la Thrombose de Bretagne Occidentale, département de médecine interne et de pneumologie, CHU de la Cavale Blanche, Brest
Presse Med 36:536-40. 2007....
Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortalityKarine Lacut
Department of Internal Medicine and Chest Diseases, G E T B O Groupe d Etude de la Thrombose de Bretagne Occidentale, Brest Cedex, France
Fundam Clin Pharmacol 21:327-33. 2007..Current antiplatelet drug use preceding the onset of ICH is associated with increased short-term ICH mortality, independently of age...
Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trialKarine Lacut
Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest Cedex, France
Atherosclerosis 174:173-80. 2004..This finding does not support a role for transdermal estrogen in the prevention of ischaemic heart disease in postmenopausal women...
Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive proteinKarine Lacut
Departement de Medecine Interne, Hopital de la Cavale Blanche, Brest, France
Thromb Haemost 90:124-31. 2003..The clinical relevance of these effects remains to be determined...
Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH StudyK Lacut
EA3878, Universite de Brest, Brest, France
J Thromb Haemost 5:2020-4. 2007..The aim of this study was to evaluate the association between the VKORC1 1173C > T polymorphism and venous thromboembolism (VTE)...
Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control studyK Lacut
EPI PHARM G E T B O, Equipe d accueil 3878, Department of Internal Medicine and Chest Diseases, Hopital de la Cavale Blanche, 29609 Brest Cedex, France
Fundam Clin Pharmacol 21:643-50. 2007..More studies are needed in order to further elucidate this adverse effect, and to determine the possible predisposing factors and the biological mechanisms involved...
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?Karine Lacut
Brest University, GETBO EA 3878, EPI PHARM, Brest, F 29609, France
Thromb Res 122:314-9. 2008..This report aims to test the hypothesis that part of these contrasting associations is related to total homocysteine level (tHcy)...
Primary prevention of venous thromboembolism in elderly medical patientsKarine Lacut
GETBO EA 3878, CHU de Brest, Department of Internal Medicine and Chest Diseases, Hôpital Cavale Blanche, Brest, France
Clin Interv Aging 3:399-411. 2008....
[Drugs and venous thromboembolism]K Lacut
EA3878, département de médecine interne et pneumologie, CHU de Brest, Universite de Bretagne Occidentale, 29609 Brest Cedex, France
Rev Pneumol Clin 64:290-7. 2008..However, certain drugs may be associated with a reduced risk of VTE. Although several studies indicate that aspirin and statins may favourably influence the risk of VTE, it is still not possible to draw up any practical recommendations...
Prevention of venous thrombosis in patients with acute intracerebral hemorrhageK Lacut
Groupe d Etude de la Thrombose de Bretagne Occidentale, Equipe d accueil 3878, Cavale Blanche Hospital, Brest, France
Neurology 65:865-9. 2005..To assess intermittent pneumatic compression (IPC) in the prevention of venous thromboembolism (VTE)...
High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxisMohamed Baba-Ahmed
Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
Thromb Haemost 97:171-5. 2007..4; 95% CI, 2.4 to 29). This study shows a close association between the presence of factorV Leiden mutation in symptomatic VTE occurring after surgery despite prophylaxis...
Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control studyE Oger
GETBO EA 3878 Groupe d Etude de la Thrombose de Bretagne Occidentale, Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
J Thromb Haemost 4:793-9. 2006..Moderate hyperhomocysteinemia and B vitamins deficiency are thought to be risk factors for venous thromboembolism (VTE). The causality and independence of those associations are still questioned...
Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control studyF Z Belattar
Brest University, France
Fundam Clin Pharmacol 24:255-9. 2010..29-0.70). In this hospital-based case-control study, a preventive role for angiotensin II receptor blockers as regards VTE risk was suggested. More studies are needed in order to further elucidate the biological mechanisms involved...
Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control studyAurelien Delluc
Université Européeenne de Bretagne, Universite de Brest, Brest, France
Thromb Haemost 103:1161-9. 2010..In this hospital-based case-control study, two polymorphisms located on the factor XI gene were significantly associated with VTE. Other newly investigated polymorphisms with potentially false negatives may warrant further analyses...
Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderlyF Couturaud
Groupe d Etude de la Thrombose de Bretagne Occidentale GETBO, Brest, France
Pathophysiol Haemost Thromb 33:362-5. 2003..In addition, the development of anticoagulation clinics and new oral anticoagulants should help to reduce anticoagulant related bleeding for an equivalent, or an increased, benefit...
[Diagnosis of postoperative venous thromboembolism]Maria Belen Moscoso
G.E.T.B.O (Groupe d'Etude de la Thrombose de Bretagne Occidentale, , , 29609 Brest
Presse Med 32:852-9. 2003..The studies targeting the management of suspected post-operative pulmonary embolism are rare and warrant further encouragement...
[Hormone therapy and risk for venous thromboembolism in postmenopausal women]Karine Lacut
, GETBO--EA 3878, , , 29609 Brest Cedex
Rev Prat 55:389-92. 2005..Whether addition of progestin plays a significant role is undetermined so far...
[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]F Couturaud
département de médecine interne et pneumologie, CHU de Brest, France
Rev Mal Respir 25:885-93. 2008....
High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderlyEmmanuel Oger
Department of Internal Medicine and Chest Diseases, Hopital de la Cavale Blanche, F 29609 Brest Cedex, France
Haematologica 88:465-9. 2003..This study aimed to test the hypothesis that an association also exists in the elderly...
High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patientsEmmanuel Oger
Groupe d Etude de la Thrombose de Bretagne Occidentale, Department of Internal Medecine and Chest Diseases, Hopital de la Cavale Blanche, F 29609 Brest Cedex, France
Thromb Haemost 88:592-7. 2002..5 to 32.6%) and 6.0 per 1,000 person-days (95% confidence interval, 0.0 to 12.7) among patients over 80 years. A high prevalence of asymptomatic deep vein thrombosis on admission was suggested particularly among elderly medical patients...
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) studyMartine Gilard
Department of Cardiology, Brest University Hospital, Brest, France
J Am Coll Cardiol 51:256-60. 2008..This trial sought to assess the influence of omeprazole on clopidogrel efficacy...
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trialEmmanuel Oger
Departement de Medecine Interne, Hopital de la Cavale Blanche, Brest, France
Arterioscler Thromb Vasc Biol 23:1671-6. 2003..Oral estrogen replacement therapy (ERT) has been reported to induce APC resistance. Little is known about the effect of transdermal estrogen...
Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolismGregoire Le Gal
EA 3878, Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
Thromb Res 121:333-8. 2007..However, clinical studies have yielded conflicting results on their possible association with venous thromboembolism (VTE)...
Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control studyKarine Lacut
Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO, Department of Internal Medicine and Chest Diseases, , 29609 Brest Cedex, France
Fundam Clin Pharmacol 18:477-82. 2004..This possible protective effect of statins warrants further investigations...
Diagnostic value of a negative single complete compression ultrasound of the lower limbs to exclude the diagnosis of deep venous thrombosis in pregnant or postpartum women: a retrospective hospital-based studyGregoire Le Gal
EA 3878 and Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
Thromb Res 118:691-7. 2006....
Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled studyEmmanuel Sonnet
Service Endocrinologie, CHU de Brest, Hôpital Cavale Blanche, Brest, France
Clin Endocrinol (Oxf) 66:626-31. 2007..This secondary analysis, based on a large randomized trial, aimed to estimate the effect of the route of administration of 17beta-oestradiol in combined hormone replacement therapy with progesterone on IGF-1 and IGFBP-3 levels...
Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH studyEmmanuel Oger
EPI PHARM GETBO and GETBO EA 3878 Groupe d Etude de la Thrombose de Bretagne Occidentale, France
Thromb Res 119:433-9. 2007..454-397 T>C and venous thromboembolism (VTE) has been reported in postmenopausal women. Comprehensive data are lacking. We herein evaluated the risk for VTE related to c.454-397 T>C ER alpha gene polymorphism in both men and women...
Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control studyEmmanuel Oger
G E T B O EA 3878 Groupe d Etude de la Thrombose de Bretagne Occidentale, Department of Internal Medicine and Chest Diseases, Brest University Hospital, 29609 Brest Cedex, France
Thromb Res 120:207-14. 2007..The hypothesis of an interaction between those risks has been raised and conflicting results were reported...
Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V LeidenFrancis Couturaud
GETBO, EA 3878, Department of Internal Medicine and Chest Diseases, University Hospital Centre La Cavale Blanche, 29609 Brest, Cedex, France
Thromb Haemost 96:744-9. 2006..FVL is associated with a two- to threefold increase in VTE in first-degree relatives of patients with VTE. No subgroup of relatives was identified who require more than routine prophylaxis because of a particularly high risk of VTE...
[Deep venous thrombosis: epidemiology, acquired risk factors]E Oger
département de médecine interne et pneumologie, Hopital de la Cavale Blanche, 29609 Brest Cedex, France
Ann Cardiol Angeiol (Paris) 51:124-8. 2002..Venous thrombosis is a multifactorial disease and analysis of the interactions between acquired and inherited risk factors is an extremely interesting field of investigation...
Management of suspected venous thromboembolism: the impact of a multifaceted interventionPierre-Yves Salaun
Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO, , F-29609 Brest Cedex, France
Int J Qual Health Care 17:433-8. 2005..CONCLUSION: No improvement in the diagnostic work-up in the event of a suspected pulmonary embolism was observed following this multifaceted intervention...
Transthoracic sonography of the lung and pleura in view of a suspected pulmonary embolism: a pilot studyKatia Mohn
Groupe d'Etude de la Thrombose de Bretagne Occidentale, Department of Internal Medicine and Chest Diseases, , Brest, France
J Ultrasound Med 22:673-8; quiz 680-1. 2003..0001). CONCLUSIONS: The results from this study suggest that transthoracic sonography of the lung does not fulfill satisfactory performance criteria in view of a clinical suspicion of pulmonary embolism...
Family history as a risk factor for venous thromboembolismSoledad Noboa
Faculté de Médecine et des Sciences de la Santé de Brest, Université de Bretagne, Occidentale UBO, Brest, France
Thromb Res 122:624-9. 2008..There are very few data assessing a family history of venous thromboembolism (VTE) as a risk factor for VTE. This question is nonetheless of interest as inherited risk factors are involved but at least partly unknown...
Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH case-control studyKarine Lacut
Haematologica 93:1117-8. 2008
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic studyIsabelle Mahe
Service Médecine Interne A, Hopital Lariboisiere, 2, rue Ambroise Pare, Paris, France
Thromb Haemost 97:581-6. 2007..Trials based on clinical end points should be conducted to evaluate the clinical relevance of these observations...
